Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury

Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury

PNAS, 2012 · DOI: 10.1073/pnas.1113953109 · Published: March 27, 2012

Spinal Cord InjuryRegenerative MedicineNeurology

Simple Explanation

The study investigates the role of ephrinB3, a protein found in myelin, in limiting axon regeneration after central nervous system (CNS) injuries. The research uses mice lacking a functional ephrinB3 gene to examine axon regeneration following optic nerve crush and spinal cord injury. The experiments showed that without ephrinB3, there was a significant increase in axon regeneration after both optic nerve and spinal cord injuries. This suggests that ephrinB3 contributes to the failure of axons to regrow after CNS trauma. The findings indicate that targeting ephrinB3 could be a therapeutic strategy to promote axon regeneration and improve recovery after CNS injuries. However, the study also notes complexities, such as altered gait and spasms in ephrinB3-deficient mice, indicating a need for careful consideration in therapeutic development.

Study Duration
25 weeks
Participants
Mice lacking a functional ephrinB3 gene and wild-type littermates
Evidence Level
Not specified

Key Findings

  • 1
    EphrinB3 contributes significantly to the inhibitory activity of myelin, restricting neurite outgrowth of dorsal root ganglion cells in vitro.
  • 2
    Mice lacking ephrinB3 show significantly increased axonal regeneration after optic nerve crush injury, demonstrating a role for ephrinB3 in limiting optic nerve regeneration in vivo.
  • 3
    After spinal cord injury, ephrinB3−/− mice exhibit improved locomotor performance and increased corticospinal and raphespinal growth in the caudal spinal cord after a dorsal hemisection injury.

Research Summary

This study demonstrates that ephrinB3, a myelin-associated protein, inhibits axonal regeneration and limits functional recovery after CNS injury. Experiments using ephrinB3-deficient mice show enhanced axon regeneration following optic nerve crush and spinal cord injury. In vitro assays confirm that myelin from ephrinB3-null mice is less inhibitory to neurite outgrowth. Following spinal cord injury, ephrinB3−/− mice exhibit improved locomotor function and increased axonal growth in the spinal cord, although extensor spasms complicate recovery after severe injury. The findings suggest that targeting ephrinB3 could be a therapeutic approach to promote axonal regeneration and improve outcomes after CNS trauma. However, the potential for developmental abnormalities and spasm phenotypes warrants careful consideration in therapeutic design.

Practical Implications

Therapeutic Target

EphrinB3 is a potential therapeutic target for promoting axonal regeneration after CNS injuries.

Combination Therapies

Combined interruption of ephrinB3 and NgR1 ligands may be more effective in promoting regeneration.

Personalized Medicine

Considering developmental abnormalities associated with ephrinB3 deficiency is important in developing therapies.

Study Limitations

  • 1
    Baseline motor impairments in ephrinB3−/− mice complicate the assessment of functional recovery after spinal cord injury.
  • 2
    Extensor spasms observed in ephrinB3−/− mice after severe spinal cord injury can limit locomotor performance.
  • 3
    The precise mechanisms underlying the injury-induced spasms in ephrinB3−/− mice remain unclear.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury